#oncology
#oncology
[ follow ]
#cancer-treatment #cancer-care #health #prostate-cancer #cancer-research #breast-cancer #patient-experience
fromFortune
4 days ago'We'll save the world from cancer': Inside Pfizer CEO's $23 billion postCOVID bet on oncology | Fortune
After leading Pfizer through the frantic race to develop the first FDA-approved COVID-19 vaccine, CEO Albert Bourla has set his sights on a new, arguably more difficult moonshot. "We saved the world from Covid, now we'll save the world from cancer," Bourla told Fortune Editor-in-Chief Alyson Shontell, outlining the company's massive pivot toward oncology following the pandemic. This ambition is backed by a historic reallocation of capital.
Medicine
fromHarvard Gazette
7 months agoUnlocking the promise of CAR-T - Harvard Gazette
They had received every other known therapy and experimental therapy - nothing worked - and after CAR-T therapy they would go into remission and just a week later, be walking around like they were totally normal, even if they got really sick during the therapy.
Cancer
Cancer
fromenglish.elpais.com
8 months agoKeys takeaways from the world's biggest cancer research conference: Trojan horses and blood tests as treatment guides
Immunotherapy is revolutionizing cancer treatment and has substantial potential, especially when used earlier and more precisely in patient profiles.
Cancer
fromwww.theguardian.com
8 months agoMy patient's cancer was curable but for years she endured painful sex as a result. This story is all too familiar | Ranjana Srivastava
Cancer survivors often face unaddressed sexual health issues that significantly impact relationships.
Healthcare providers lack training in managing sexual health concerns for cancer patients.
Survivorship should encompass the holistic well-being of the patient, including sexual health.
#cancer-research
Cancer
fromNature
9 months agoClinical trials by the numbers
Cancer is the second leading cause of death globally, requiring urgent advancements in diagnosis and treatment to keep pace with the rising incidence.
Emerging biopharmaceutical companies are increasingly dominating the oncology clinical trial landscape, reflecting their growing importance in cancer research.
Startup companies
fromSilicon Canals
9 months agoAmsterdam's Avidicure exits stealth mode with 43.8M to develop new antibody therapies - Silicon Canals
Avidicure launched with $50M funding to develop multifunctional antibodies for cancer treatment, aiming to revolutionize oncology with innovative therapies.
[ Load more ]